Viral hepatitis and drug use in Europe

Publications

Viral hepatitis and drug use in Europe

29 September 2014

This publication has been produced with the financial support of the Drug Prevention and Information Programme (DPIP) of the European Union. The contents of this publication are the sole responsibility of the authors and can in no way be taken to reflect the view of the European Commission. The publication charges for this supplement were funded by AbbVie as an unresitricted grant to Rigshospitalet, the University of Copenhagen, Denmark.

Introduction

Hepatitis – a devastating epidemic in Europe

Jeffrey V Lazarus, Kevin A FentonBMC Infectious Diseases 2014, 14(Suppl 6):S1 (19 September 2014)

Full text | PDF | PubMed

Commentary

No strategy to meet the HCV epidemic

Olav Dalgard, Stefan MaussBMC Infectious Diseases 2014, 14(Suppl 6):S2 (19 September 2014)

Full text | PDF | PubMed

Commentary

Improved hepatitis C screening and treatment in people who inject drugs should be a priority in Europe

Achim Kautz, Lilyana Chavdarova, Margaret WalkerBMC Infectious Diseases 2014, 14(Suppl 6):S3 (19 September 2014)

Full text | PDF | PubMed

Commentary

Ending the mass criminalisation of people who use drugs: a necessary component of the public health response to hepatitis C

Chris Ford, Juliet BressanBMC Infectious Diseases 2014, 14(Suppl 6):S4 (19 September 2014)

Full text | PDF | PubMed

Commentary

A treatment revolution for those who can afford it? Hepatitis C treatment: new medications, profits and patients

Maria Phelan, Catherine CookBMC Infectious Diseases 2014, 14(Suppl 6):S5 (19 September 2014)

Full text | PDF | PubMed

Commentary

A national multidisciplinary healthcare network for treatment of hepatitis C in people who inject drugs in Slovenia

Mojca MaticicBMC Infectious Diseases 2014, 14(Suppl 6):S6 (19 September 2014)

Full text | PDF | PubMed

Commentary

The successful implementation of Scotland’s Hepatitis C Action Plan: what can other European stakeholders learn from the experience? A Scottish voluntary sector perspective

Leon Wylie, Sharon Hutchinson, David Liddell, Nicola RowanBMC Infectious Diseases 2014, 14(Suppl 6):S7 (19 September 2014)

Full text | PDF | PubMed

Commentary

Improving the quality of needle and syringe programmes: an overlooked strategy for preventing hepatitis C among people who inject drugs

Astrid LeichtBMC Infectious Diseases 2014, 14(Suppl 6):S8 (19 September 2014)

Full text | PDF | PubMed

Commentary

Consensus for the integrated management of hepatitis C in Portugal

Ricardo LeiteBMC Infectious Diseases 2014, 14(Suppl 6):S9 (19 September 2014)

Full text | PDF | PubMed

Commentary

A perspective from drug user organisations on ‘ECDC and EMCDDA guidance: prevention and control of infectious diseases among people who inject drugs’

Antonio Corbacho, Manuel Rivera, Francisco Trujillo, Maite Martí, José Carbonell, Francisco Fernández, Alexandre Rosselló, Jordi Perramon, Jaume Salse, Ignacio RamosBMC Infectious Diseases 2014, 14(Suppl 6):S10 (19 September 2014)

Full text | PDF | PubMed

Commentary

A policy-maker’s perspective on ‘ECDC and EMCDDA guidance: prevention and control of infectious diseases among people who inject drugs’

Joan Colom I FarranBMC Infectious Diseases 2014, 14(Suppl 6):S11 (19 September 2014)

Full text | PDF | PubMed

Research

Hepatitis C virus seroprevalence among people who inject drugs and factors associated with infection in eight Russian cities

Robert Heimer, Ksenia Eritsyan, Russell Barbour, Olga S LevinaBMC Infectious Diseases 2014, 14(Suppl 6):S12 (19 September 2014)

Abstract | Full text | PDF | PubMed

Review

HIV and hepatitis C co-infection in Europe, Israel and Argentina: a EuroSIDA perspective

Lars Peters, Amanda Mocroft, Jens Lundgren, Daniel Grint, Ole Kirk, Jürgen RockstrohBMC Infectious Diseases 2014, 14(Suppl 6):S13 (19 September 2014)

Full text | PDF | PubMed

Research

Are there national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs? A survey of 33 European countries

Mojca Maticic, Jerneja Videcnik Zorman, Sergeja Gregorcic, Eberhard Schatz, Jeffrey V LazarusBMC Infectious Diseases 2014, 14(Suppl 6):S14 (19 September 2014)

Abstract | Full text | PDF | PubMed

Research

Policy responses to viral hepatitis B and C among people who inject drugs in Member States of the WHO European region: a sub-analysis of the WHO 2013 global hepatitis policy survey

Alexander Spina, Irina Eramova, Jeffrey V LazarusBMC Infectious Diseases 2014, 14(Suppl 6):S15 (19 September 2014)

Abstract | Full text | PDF | PubMed

Research

A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region

Jeffrey V Lazarus, Ida Sperle, Mojca Maticic, Lucas WiessingBMC Infectious Diseases 2014, 14(Suppl 6):S16 (19 September 2014)

Abstract | Full text | PDF | PubMed

Review

Hepatitis C in European prisons: a call for an evidence-informed response

Amber Arain, Geert Robaeys, Heino StöverBMC Infectious Diseases 2014, 14(Suppl 6):S17 (19 September 2014)

Abstract | Full text | PDF | PubMed

Roundtable

Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis

Jeffrey V Lazarus, Jens Lundgren, Jordi Casabona, Lucas Wiessing, Catharina Matheï, Peter Vickerman, Maria Prins, Mirjam Kretzschmar, Maria Kantzanou, Isabelle Giraudon, Marica Ferri, Paul Griffiths, Magdalena Harris, Margaret Walker, Lilyana Chavdarova, Eberhard Schatz, Katrin Schiffer, John Kools, Jason Farell, Luís MendãoBMC Infectious Diseases 2014, 14(Suppl 6):S18 (19 September 2014)

Full text | PDF | PubMed

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.